Crestline Management’s ICU Medical ICUI Stock Holding History

Crestline Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,521	Closed	-$2.73M	–	292
2021 Q4	$2.73M	Buy	+11,521	New	+$2.69M	0.2%	101

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Crestline Management's ICUI Position: Q1 2022 in Review

Crestline Management sold out of ICU Medical (ICUI) in Q1 2022, closing a stake of 11,521 shares — an estimated $2.73M sold.

Crestline Management first reported a position in ICUI in Q4 2021 and held it in 1 quarter. The position peaked at $2.73M in Q4 2021. 295 funds tracked by Wall St. Rank hold ICUI as of Q1 2022.

Crestline Management reported no remaining ICU Medical position as of Q1 2022 after selling out during the quarter.
Crestline Management sold 11,521 ICU Medical shares in Q1 2022, an estimated $2.73M.
Crestline Management first reported a position in ICU Medical in Q4 2021 and held it in 1 quarter.
Crestline Management's ICU Medical position peaked at $2.73M in Q4 2021.
295 funds tracked by Wall St. Rank held ICU Medical as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.